Cholangiopancreatoscopy using SpyGlass^TM direct visualization system: description of the method and initial experience

Česká verze

Authors: O. Urban ^1,2; U. Arnelo ³; M. Kliment ¹; P. Fojtík ¹; Přemysl Falt ¹ ; M. Hanousek ¹; V. Zoundijekpon ¹; E. Kundratová ¹; T. Málek ⁴; P. Holéczy ^2,5
Authors place of work: Vzdělávací a výzkumný institut AGEL, o. p. s. – pobočka Ostrava-Vítkovice, Vítkovická nemocnice a. s., Centrum péče o zažívací trakt ¹; Lékařská fakulta, Ostravská univerzita v Ostravě ²; Division of Surgery, CLINTEC, Karolinska Institutet and Department of Surgical Gastroenterology, Karolinska University Hospital, Stockholm, Sweden ³; Anesteziologicko-resuscitační oddělení, Vítkovická nemocnice, Ostrava ⁴; Chirurgické oddělení, Vítkovická nemocnice, Ostrava, a Katedra chirurgických oborů OSU, Ostrava ⁵
Published in the journal: Gastroent Hepatol 2013; 67(2): 124-126
Category: Digestivní endoskopie: původní práce

Summary

SpyGlass^TM direct visualization system enables endoscopic examination of the biliary tract and the pancreatic duct. The most important indications are indeterminate biliary lesion, indeterminate pathology of the pancreatic duct and treatment of serious choledocholithiasis. The treatment results of 13 patients are presented here.

Key words:
cholangioscopy –⁠ SpyGlass –⁠ endoscopic retrograde cholangiopancreatography

Zdroje

1. Chen YK, Pleskow DK. SpyGlass single--operator peroral cholangiopancreatoscopy system for the diagnosis and therapy of bile-duct disorders: a clinical feasibility study (with video). Gastrointest Endosc 2007; 65(6): 832–841.

2. Chen YK, Parsi MA, Binmoeller KF et al. Single-operator cholangioscopy in patients requiring evaluation of bile duct disease or therapy of biliary stones (with videos). Gastrointest Endosc 2011; 74(4): 805–814.

3. Sakamoto H, Kitano M, Kamata K et al. Transcatheter endoscopy for pancreaticobiliary duct diseases (with videos). Gastrointest Endosc 2012; 76(4): 892–899.

4. Draganov PV, Chauhan S, Waqh MS. Diagnostic accuracy of conventional and cholangioscopy-guided sampling of indeterminate biliary lesions at the time of ERCP: a prospective, long-term follow-up study. Gastrointest Endosc 2012; 75(2): 347–353.

5. Moslem P. Cholangiopancreatoscopy: risks and benefits. Gastrointest Endosc 2011; 73(2): 257–259.

6. D'souza MA, Isaksson B, Löhr M et al. The clinicopathological spectrum and management of intraductal papillary mucinous neoplasm of the bile duct (IPMN-B). Scand J Gastroenterol 2013; 48(4): 473–479.